发明名称 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
摘要 Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin. Specifically disclosed is and EPO production enhancer and/or a hemoglobin production enhancer comprising a 1-acyl-4-(substituted oxy, substituted amino, or substituted thio)-1,2,3,4-tetrahydroquinoline derivative, more specifically a tetrahydroquinoline compound represented by general formula (1) [wherein R1, R2, R2′, R3 and R3′ independently represent a hydrogen atom, a C1-6 alkyl group, or the like; R4, R5, R6, R7, R8, R9 and R10 independently represent a hydrogen atom, a halogen atom, a C1-6 alkyl group, or the like; A represents N—R11, a sulfur atom, or an oxygen atom; R11 represents a hydrogen atom, a C1-6 alkyl group, or the like; B represents a C6-14 aryl group, or a 5- to 10-membered heterocyclic group; and n represents an integer of 0 or 1], a salt of the tetrahydroquinoline compound, or a solvate of the tetrahydroquinoline compound or the salt.
申请公布号 US9045423(B2) 申请公布日期 2015.06.02
申请号 US201414274805 申请日期 2014.05.12
申请人 KOWA COMPANY, LTD. 发明人 Ashikawa Masanori;Tagashira Junya;Koketsu Akiyasu;Morimoto Toshiharu;Kitamura Takahiro;Takemura Syunji;Watanabe Gen;Nishiyama Tatsuaki;Goda Satoshi;Yamabi Masaki;Doi Takeshi;Ishiwata Hiroyuki
分类号 A01N57/26;A61K31/675;C07D215/42;A61K31/47;A61K31/4706;A61K31/4709;A61K31/496;A61K31/5377;A61K31/69;C07D215/233;C07D215/44;C07D215/46;C07D215/48;C07D401/04;C07D401/12;C07D413/04;C07D413/12;C07D417/12;C07D405/12 主分类号 A01N57/26
代理机构 Westerman, Hattori, Daniels & Adrian, LLP 代理人 Westerman, Hattori, Daniels & Adrian, LLP
主权项 1. A tetrahydroquinoline compound, a salt thereof, or a solvate of the compound, wherein the tetrahydroquinoline compound is 1-acetyl-4-[(4-chlorophenyl)amino]-2-methyl-1,2,3,4-tetrahydroquinoline-6-carboxamide (compound 43).
地址 Nagoya-shi JP